You are looking at 1 - 6 of 6 items for :
- eGFR x
- Clinical Care x
- Refine by Content Type: All x
In a joint statement, the American Society of Nephrology (ASN) and the National Kidney Foundation (NKF) commended the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Diseases for submitting its final report for publication.
Reaffirming that race is a social, not a biological, construct, ASN remains committed to ensuring that racial and ethnic biases do not affect the diagnosis and treatment of kidney diseases.
Last month, ASN and NKF asserted that race should not be included in kidney function estimating equations and that a suitable approach be put in its place that is accurate; representative for all regardless of race, ethnicity, age, or sex; not differentially produce bias, inaccuracy, or inequalities; and be standardized across the United States. Producing such a national standard depends on coordinating efforts to replace the existing equations for estimating kidney function with a suitable approach.
Today, the Journal of the American Society of Nephrology (JASN) and the American Journal of Kidney Diseases (AJKD) published the interim report of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease.
ASN and the National Kidney Foundation (NKF) would like to announce open forums for anyone interested in providing input into the final report of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Diseases.
In January 2021, the task force will host three live forums in which individuals can testify (or provide written comments) on relevant topics, including but not limited to, health care disparities for Black or African American, Hispanic or Latino, American Indian or Alaska Native, Asian American, or Native Hawaiian or Other Pacific Islander people; kidney function measurement; patient safety/standardization and new or innovative approaches to kidney function measurement; and measurement or reporting that does not include race.
In August of 2020, the National Kidney Foundation (NKF) and the American Society of Nephrology (ASN) formed a joint task force to focus on the use of race to estimate GFR. For more information, please read the joint NKF-ASN statement on “Establishing a Task Force to Reassess the Inclusion of Race in Diagnosing Kidney Diseases.”
On July 2, the American Society of Nephrology (ASN) and the National Kidney Foundation (NKF) released a joint statement announcing the establishment of a joint task force that aims to reassess the includsion of race in diagnosing kidney diseases.
"Of the more than 37 million people affected by kidney diseases in the United States, a disproportionate number are of African American, Hispanic, Asian, and Native American descent. African Americans are three times more likely than Non-Hispanic Whites to experience kidney failure. Such disparities go beyond the high prevalence of kidney diseases and extend into differences in treatment modality, including access to transplantation. While African Americans represent 35% of people receiving dialysis in the United States, they are less likely to be identified as kidney transplant candidates when compared to Non-Hispanic White," begins the statment.